1-8 of 8
Paul S. Albert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer

Free
Andrea L. Russo, Kimberly Jedlicka, Meredith Wernick, Debbie McNally, Melissa Kirk, Mary Sproull, Sharon Smith, Uma Shankavaram, Aradhana Kaushal, William D. Figg, William Dahut, Deborah Citrin, Donald P. Bottaro, Paul S. Albert, Philip J. Tofilon, Kevin Camphausen
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (13): 4292–4298.
https://doi.org/10.1158/1078-0432.CCR-09-0599
Published: 01 July 2009
View articletitled, Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer
Open the PDF for Urine Analysis and Protein Networking Identify Met as a Marker of Metastatic Prostate Cancer in another window
Journal Articles

A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas

Free
Teri N. Kreisl, Lyndon Kim, Kraig Moore, Paul Duic, Svetlana Kotliarova, Jennifer Walling, Luna Musib, Donald Thornton, Paul S. Albert, Howard A. Fine
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3617–3623.
https://doi.org/10.1158/1078-0432.CCR-08-3071
Published: 18 May 2009
View articletitled, A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas
Open the PDF for A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas in another window
Includes: Supplementary data
Journal Articles

EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies

Free
Deirdre O'Mahony, John C. Morris, Maryalice Stetler-Stevenson, Helen Matthews, Margaret R. Brown, Thomas Fleisher, Stefania Pittaluga, Mark Raffeld, Paul S. Albert, Dirk Reitsma, Karen Kaucic, Luz Hammershaimb, Thomas A. Waldmann, John E. Janik
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (7): 2514–2522.
https://doi.org/10.1158/1078-0432.CCR-08-1254
Published: 01 April 2009
View articletitled, EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies
Open the PDF for EBV-Related Lymphoproliferative Disease Complicating Therapy with the Anti-CD2 Monoclonal Antibody, Siplizumab, in Patients with T-Cell Malignancies in another window
Includes: Supplementary data
Journal Articles

Multimodality Therapy: Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease

Free
Diane E. Milenic, Kayhan Garmestani, Erik D. Brady, Kwamena E. Baidoo, Paul S. Albert, Karen J. Wong, Joseph Flynn, Martin W. Brechbiel
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (16): 5108–5115.
https://doi.org/10.1158/1078-0432.CCR-08-0256
Published: 12 August 2008
View articletitled, Multimodality Therapy: Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease
Open the PDF for Multimodality Therapy: Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease in another window
Journal Articles

A Phase I Trial of Lenalidomide in Patients with Recurrent Primary Central Nervous System Tumors

Free
Howard A. Fine, Lyndon Kim, Paul S. Albert, J. Paul Duic, Hilary Ma, Wei Zhang, Tanyifor Tohnya, William D. Figg, Cheryl Royce
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (23): 7101–7106.
https://doi.org/10.1158/1078-0432.CCR-07-1546
Published: 03 December 2007
View articletitled, A Phase I Trial of Lenalidomide in Patients with Recurrent Primary Central Nervous System Tumors
Open the PDF for A Phase I Trial of Lenalidomide in Patients with Recurrent Primary Central Nervous System Tumors in another window
Journal Articles

Nuclear Factor-κB–Related Serum Factors as Longitudinal Biomarkers of Response and Survival in Advanced Oropharyngeal Carcinoma

Free
Clint Allen, Sonia Duffy, Theodoros Teknos, Mozaffarul Islam, Zhong Chen, Paul S. Albert, Gregory Wolf, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (11): 3182–3190.
https://doi.org/10.1158/1078-0432.CCR-06-3047
Published: 01 June 2007
View articletitled, Nuclear Factor-κB–Related Serum Factors as Longitudinal Biomarkers of Response and Survival in Advanced Oropharyngeal Carcinoma
Open the PDF for Nuclear Factor-κB–Related Serum Factors as Longitudinal Biomarkers of Response and Survival in Advanced Oropharyngeal Carcinoma in another window
Journal Articles

Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease

Free
Diane E. Milenic, Kayhan Garmestani, Erik D. Brady, Paul S. Albert, Alia Abdulla, Joseph Flynn, Martin W. Brechbiel
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1926–1935.
https://doi.org/10.1158/1078-0432.CCR-06-2300
Published: 15 March 2007
View articletitled, Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease
Open the PDF for Potentiation of High-LET Radiation by Gemcitabine: Targeting HER2 with Trastuzumab to Treat Disseminated Peritoneal Disease in another window
Journal Articles

Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease

Free
Diane E. Milenic, Kayhan Garmestani, Erik D. Brady, Paul S. Albert, Dangshe Ma, Alia Abdulla, Martin W. Brechbiel
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (23): 7834–7841.
https://doi.org/10.1158/1078-0432.CCR-04-1226
Published: 07 December 2004
View articletitled, Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease
Open the PDF for Targeting of HER2 Antigen for the Treatment of Disseminated Peritoneal Disease in another window